|
|
|
|
|
|
by gruez
667 days ago
|
|
|
>because the generic drug might not be good enough in your case. The comment I was replying to: >Often times, you’re looking at 10-100x the cost for “statistically significant” uplift in efficacy. What happened to value-based medicine? If that's the case, sounds like the extra cost is worth it. |
|
|